p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression. (Q36622181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Creaney J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

McLaren BM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Stevenson S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Robinson BW

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Lake RA

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

52-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1529

3 November 2019

exact match

0 references

cites work

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

p53/T-antigen complex disruption in T-antigen transformed NIH3T3 fibroblasts exposed to oxidative stress: correlation with the appearance of a Fas/APO-1/CD95 dependent, caspase independent, necrotic pathway

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Regulation of p53 stability

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

New molecular and epidemiological issues in mesothelioma: role of SV40.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Role of amplified genes in the production of autoantibodies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

p53, the cellular gatekeeper for growth and division

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

High levels of MDM2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Immunity to Oncogenic Proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Detection of preoperative serum anti-p53 antibodies in gastric cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Sera from patients with malignant mesothelioma can contain autoantibodies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

p53 and Kirsten-ras mutations in human mesothelioma cell lines

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363614

p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells

20 September 2018

1 reference

12 December 2020

Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium

1 reference

12 December 2020

Interferon alpha and doxorubicin in malignant mesothelioma: a phase II study

1 reference

12 December 2020

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1 reference

12 December 2020

The role of anti-p53-autoantibodies in pancreatic disorders

1 reference

12 December 2020

Absence of p53 mutations in malignant mesotheliomas

1 reference

12 December 2020

p53 immunostaining in differential diagnosis of pleural mesothelial proliferations

1 reference

12 December 2020

Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer

1 reference

12 December 2020

Intralesional cytokine therapy in cancer: a pilot study of GM-CSF infusion in mesothelioma

1 reference

12 December 2020

p53 antibodies in patients with various types of cancer: assay, identification, and characterization

1 reference

12 December 2020

p53 autoantibodies in patients with urological tumours

1 reference

12 December 2020

Somatic genetic alterations in human malignant mesothelioma (review)

1 reference

12 December 2020

Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer

1 reference

12 December 2020

A new prognostic indicator for head and neck cancer--p53 serum antibodies?

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 November 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11139313%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

11139313

1 reference